Evaluation and Improvement of Oncologists' Adherence to NCCN Guideline for Prevent and Treatment of Cancer Associated Venous Thromboembolism
DOI:
https://doi.org/10.22317/jcms.v10i5.1634Keywords:
Cancer, venous thromboembolism, Anticoagulant therapy, NCCN guideline, AdherenceAbstract
Objective: the aim of this study is asses the adherence of physician to NCCN guideline recommended anticoagulant therapy in patient with cancer associated venous thromboembolism.
Method: study was designed with two phases an observational phase and an interventional prospective phase with the educational program, was conducted at Middle Euphrates cancer center /An-Najaf governorate/Iraq. Ten oncologists who agreed to participate in the study. Used validated questionnaire include (25 items) where distributed to 10 oncologists who were working at the Middle Euphrates cancer center then all questionnaires were collected from participated oncologists over two months. Subsequently, an educational part including a lecture and posters was submitted in cancer center to in raising awareness of seriousness of this disease and how prevention and treatment.
Results: The overall mean total score of oncologists for prevention and management of cancer associated VTE (out of 25 items) of all questionnaire parts was remarkably increased from (0.54) to (0.72) after the intervention therefore the level of oncologist's adherence to NCCN guideline improved to 70% with large effect size (1.04).
Conclusion: According to the final evaluation of responses of oncologists showed improvement in adherence toward the NCCN guideline. In addition, there were several barriers that mainly reduce the adherence like sever side effect, increase cost and Lack of awareness of guidelines.
References
Bouillaud, S., & Bouillaud, J. (1823). De l’Obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general. Arch Gen Med, 1(2), 188–204.
Trousseau, A. (1865). Phlegmasia alba dolens. Clinique Medicale de l’Hotel-Dieu de Paris., 94.
Ikeda, S., Koga, S., Yamagata, Y., Eguchi, M., Sato, D., Muroya, T., Yonekura, T., Tsuneto, A., Yoshimuta, T., & Koide, Y. (2018). Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancer. Journal of Cardiology, 72(2), 120–127.
Lyman, G. H., Khorana, A. A., Falanga, A., Clarke-Pearson, D., Flowers, C., Jahanzeb, M., Kakkar, A., Kuderer, N. M., Levine, M. N., & Liebman, H. (2007). American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Journal of Clinical Oncology, 25(34), 5490–5505.
Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007b). Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. Journal of Thrombosis and Haemostasis, 5(3), 632–634.
Carrier, M., Le Gal, G., Wells, P. S., Fergusson, D., Ramsay, T., & Rodger, M. A. (2008). Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Annals of Internal Medicine, 149(5), 323–333.
Mukai, M., & Oka, T. (2018). Mechanism and management of cancerassociated thrombosis. Journal of Cardiology, 72(2), 89–93.
Hisada, Y., & Mackman, N. (2017). Cancer-associated pathways and biomarkers of venous thrombosis. Blood, The Journal of the American Society of Hematology, 130(13), 1499–1506.
Varki, A. (2007). Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood, The Journal of the American Society of Hematology, 110(6), 1723–1729.
Horsted, F., West, J., & Grainge, M. J. (2012). Risk of venous thromboembolism in patients with cancer: a systematic review and metaanalysis. PLoS Med, 9(7), e1001275.
Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007a). Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer: Interdisciplinary International Journal of the American Cancer Society, 110(10), 2339–2346.
Mansfield, A. S., Tafur, A. J., Wang, C. E., Kourelis, T. V, Wysokinska, E. M., & Yang, P. (2016). Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer. Journal of Thrombosis and Haemostasis, 14(9), 1773–1778.
Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Elshoury, A., Fanikos, J., Fertrin, K. Y., Fogerty, A. E., Gao, S., & Goldhaber, S. Z. (2021). Cancerassociated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 19(10), 1181–1201.
Fernandes, C. J., Morinaga, L. T. K., Alves, J. L., Castro, M. A., Calderaro, D., Jardim, C. V. P., & Souza, R. (2019). Cancer-associated thrombosis: the when, how and why. European Respiratory Review, 28(151).
Al-Tawfiq, J. A., & Saadeh, B. M. (2011). Improving adherence to venous thromoembolism prophylaxis using multiple interventions. Annals of Thoracic Medicine, 6(2), 82.
Kandemir, E. A., Bayraktar-Ekincioglu, A., & Kilickap, S. (2021). Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist’s impact on anticoagulant therapy. Supportive Care in Cancer, 29, 1699–1709.
Cook, D., Duffett, M., Lauzier, F., Ye, C., Dodek, P., Paunovic, B., Fowler, R., Kho, M. E., Foster, D., & Stelfox, T. (2014). Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter survey. Journal of Critical Care, 29(3), 471–e1.
Zierler, B. K., Meissner, M. H., Cain, K., & Strandness Jr, D. E. (2002). A survey of physicians’ knowledge and management of venous thromboembolism. Vascular and Endovascular Surgery, 36(5), 367–375.
Kucher, N., Koo, S., Quiroz, R., Cooper, J. M., Paterno, M. D., Soukonnikov, B., & Goldhaber, S. Z. (2005). Electronic alerts to prevent venous thromboembolism among hospitalized patients. New England Journal of Medicine, 352(10), 969–977.
Anderson, F. A., Wheeler, H. B., Goldberg, R. J., Hosmer, D. W., Forcier, A., & Patwardhan, N. A. (1994). Changing clinical practice: prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Archives of Internal Medicine, 154(6), 669–677.
Scaglione, L., Piobbici, M., Pagano, E., Ballini, L., Tamponi, G., & Ciccone, G. (2005). Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica, 90(5), 678–684.
Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P.-A. C., & Rubin, H. R. (1999). Why don’t physicians follow clinical practice guidelines?: A framework for improvement. Jama, 282(15), 1458–1465.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
